select semaglutide 2.4 mg delivered a statistically significant 20% risk reduction in major adverse cardiovascular events – REGENHEALTHSOLUTIONS (RHS) SELECT Cardiovascular Trial Information |

Insurance coverage varies wildly

But the gap between 8mg and 12mg is narrower than the gap between 4mg and 8mg

Always follow your healthcare provider's specific instructions for dosing and administration

Created with BioRender.com Background GLP-1R, a member of the class B family of G protein-coupled receptors (GPCRs or secretin-like receptors), is a transmembrane protein primarily found in pancreatic cells and brain neurons and is activated by the peptide hormone glucagon-like peptide 1 (GLP-1) and glucagon that is secreted from intestinal L-cells after nutrient ingestion

11 Despite the promise of these medications, they are accompanied by significant risks, including gastrointestinal issues, pancreatitis, kidney failure, gallbladder disease, and thyroid cancer